nwinnovation
High Technology News and Information for the Pacific Northwest Region
Home
Mobile
News and Events
  • Headlines
  • Interviews
  • Events
  • Jobs
  • VC Funds
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
  • People
  • Exits
  • VentureMap
  • PowerSearch
  • FundingSearch
  • Stats
  • Dashboard
  • Satellite
  • Post Jobs
    • About
  • About
  • Contact Us
    		•
    Search News
    Subscribe with Bloglines Subscribe in NewsGator Online Add to My Yahoo
    Thursday, July 20, 2006

    Gilead To Acquire Corus Pharma For $365M


    Gilead Sciences is acquiring Seattle-based Corus Pharma in a deal worth $365M, the firm said yesterday. Gilead said that it has agreed to exercise its option to acquire the firm, which is commercialization products for treating respiratory and infection diseases. Corus is backed by Bear Stearns Health Innoventures, Burrill & Company, JPMorgan Partners (now known as Panorama Capital), Novo A/S, Orbimed Advisors and others.
    posted on Thursday, July 20, 2006


    Related stories:
    > CheckFree Buys Corillian
    > Microsoft Revives Talks with Yahoo
    > Microsoft To Acquire Musicwave
    > F5 Networks to Acquire Acopia for $210M
    > RadiSys To Acquire IP Media Firm For $105M
    Sign up to receive updates via our daily email newsletter

    Enter your email:


    Previous Issues

     Friday, September 5, 2008
    Thursday, September 4, 2008
    Wednesday, September 3, 2008
    Tuesday, September 2, 2008
    Friday, August 29, 2008